📣@EMA_News has adopted a positive opinion of fexinidazole for the treatment of T.b. rhodesiense #sleepingsickness. This is the result of years of #InnovatingTogether with @sanofi & the HAT-r-ACC consortium to find a better & safer cure 💊 for patients! bit.ly/46Xmabw
2
27
60
10K
1
@EMA_News @sanofi Results from clinical trials that we conducted with the HAT-r-ACC consortium in Malawi & Uganda showed that fexinidazole was highly effective in treating T.b. rhodesiense #sleepingsickness and a safe alternative to the existing drugs. bit.ly/3RG8Iof #beatNTDs